News & Updates

Children with type 2 diabetes (T2D) face a strikingly high complication rate as they become young adults, with an 80 percent incidence of at least one vascular complication, as shown in the TODAY* study.

A simple device for atrial fibrillation (AF) screening, MyDiagnostick, demonstrates high sensitivity and specificity when used in Asians, reports a study in Singapore. Moreover, it can be reliably used by nonspecialist professionals in the community setting.

People who consume high amounts of ultra-processed foods (UPFs) appear to be at heightened risk of cardio-cerebrovascular diseases (CCVDs), according to the results of a systematic review and meta-analysis.

Adherence to ketogenic diets (KDs) results in weight reduction and increased aldosterone concentrations without worsening cardiometabolic risk factors, suggests a study.

Treatment with once-weekly tirzepatide, a GIP* and GLP-1** receptor agonist, led to a substantial weight reduction among overweight or obese adults with type 2 diabetes (T2D), according to the phase III SURMOUNT-2 trial presented at ADA 2023.

Treatment with tirzepatide is associated with better lipid profile and waist circumference outcomes compared with placebo and other glucose-lowering drugs, according to a study.